Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by PALMER, M.
Right arrow Articles by LJUNGHALL, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PALMER, M.
Right arrow Articles by LJUNGHALL, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 127, No. 5: 1031-1040
Copyright © 1988 by The Johns Hopkins University School of Hygiene and Public Health


research-article

INCREASED RISK OF MALIGNANT DISEASES AFTER SURGERY FOR PRIMARY HYPERPARATHYROIDISM

A NATIONWIDE COHORT STUDY

MATS PALMER1, HANS-OLOV ADAMI2, ULLA BRITH KRUSEMO3 and SVERKER LJUNGHALL1

1Department of Internal Medicine, University Hospital Uppsala, Sweden
2Department of Surgery, University Hospital Uppsala, Sweden
3Data Center, Uppsala University Uppsala, Sweden

Reprint requests to Dr. Sverker Ljunghall, Department of Medicine, University Hospital, S-751 85 Uppsala, Sweden

A cohort of 4,163 persons reported to the nationwide Swedish Cancer Registry by reason of hyperparathyroidism was followed for up to 22 completed years (24,593 person-years of observation). The occurrence of malignant disease manifested after parathyroid surgery was investigated through computerized linkage to the entire Cancer Registry. During the entire period, the hyperparathyroidism patients suffered malignant diseases significantly more often than the background population (relative risk (RR) = 1.6, 95% confidence interval (Cl) 1.5-1.8). Even if all cases with malignant diseases detected at the same time as hyperparathyroidism or during the first year after parathyroid surgery were eliminated, a significantly increased risk remained for the following years (RR = 1.4, 95% Cl 1.2–1.6). A significantly increased relative risk of developing gastrointestinal cancers, endocrine tumors, kidney carcinomas, and mammary carcinomas was found. During the first postoperative year, an increased surveillance of the cohort is likely to have contributed to the increased risk, but detection bias is considered unlikely to be the only explanation for the higher risk during all subsequent years. The findings indicate that hyperparathyroidism either promotes later development of malignant tumors or that this condition and certain malignant diseases have etiologic factors in common.

hypercalcemia; hyperparathyroidism; prospective studies


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Siilin, J. Rastad, O. Ljunggren, and E. Lundgren
Disturbances of Calcium Homeostasis Consistent with Mild Primary Hyperparathyroidism in Premenopausal Women and Associated Morbidity
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 47 - 53.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
I.-L. Nilsson, J. Zedenius, L. Yin, and A. Ekbom
The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy
Endocr. Relat. Cancer, March 1, 2007; 14(1): 135 - 140.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
A. Cranney, A. Papaioannou, N. Zytaruk, D. Hanley, J. Adachi, D. Goltzman, T. Murray, A. Hodsman, and for the Clinical Guidelines Committee of Osteoporo
Parathyroid hormone for the treatment of osteoporosis: a systematic review.
Can. Med. Assoc. J., July 4, 2006; 175(1): 52 - 59.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. Grey, M. Bolland, and I. R. Reid
Evaluation and Treatment of Primary Hyperparathyroidism
JAMA, December 7, 2005; 294(21): 2699 - 2700.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Bolland, A. B. Grey, G. D. Gamble, and I. R. Reid
Association between Primary Hyperparathyroidism and Increased Body Weight: A Meta-Analysis
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1525 - 1530.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
E. Kebebew, Q.-Y. Duh, and O. H. Clark
Parathyroidectomy for Primary Hyperparathyroidism in Octogenarians and Nonagenarians: A Plea for Early Surgical Referral
Arch Surg, August 1, 2003; 138(8): 867 - 871.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. M. Neer, C. D. Arnaud, J. R. Zanchetta, R. Prince, G. A. Gaich, J.-Y. Reginster, A. B. Hodsman, E. F. Eriksen, S. Ish-Shalom, H. K. Genant, et al.
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
N. Engl. J. Med., May 10, 2001; 344(19): 1434 - 1441.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.